Clinical Trials List
2018-06-01 - 2023-03-21
Phase III
Terminated6
ICD-10F03.90
Unspecified dementia without behavioral disturbance
ICD-10G30
Alzheimer's disease
-
Trial Applicant
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/04/01
Investigators and Locations
Co-Principal Investigator
- TA-FU CHEN Division of Neurology
- 高伊慧 Division of Neurology
- RUOH-FANG YEN Division of Nuclear Medicine
- YA-FANG CHEN Division of Radiology
The Actual Total Number of Participants Enrolled
0 Terminated
Audit
None
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Chien-Hsun Li Division of Neurology
- MEI-CHUAN CHOU Division of Neurology
- PING SONG CHOU Division of Neurology
- Chiou-Lian Lai Division of Neurology
- 吳孟霓 Division of Neurology
- Ching-Kuan Liu Division of Neurology
- Cheng-Fang Hsieh Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
- Wei-Shih Huang Division of Neurology
- Kuan-Fei Chen Division of Neurology
- Kang-Hsu Lin Division of Neurology
- Hui-Chun Huang Division of Neurology
- Yuh-Cherng Guo Division of Neurology
- Ming-Kuei Lu Division of Neurology
- Ching-Hua Lu Lu Division of Neurology
- Jui-Cheng Chen Division of Neurology
- Chon-Haw Tsai Division of Neurology
- Yi-Ting Hsu Division of Neurology
- Fu-Yu Lin Division of Neurology
The Actual Total Number of Participants Enrolled
0 Terminated
Co-Principal Investigator
Audit
CRO
Taiwan National PI
Co-Principal Investigator
- Kun-Ju Lin Division of Nuclear Medicine
- Tzu-Chen Yen Division of Nuclear Medicine
- KuoLun Huang Division of Neurology
The Actual Total Number of Participants Enrolled
2 Terminated
Audit
None
Co-Principal Investigator
Audit
CRO
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
30 participants
-
Global
1016 participants
